New DNA scanner could speed up treatment for diabetic foot infections

NCT ID NCT07391995

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a portable DNA device called MinION that can identify bacteria and fungi in foot wounds of people with diabetes in under 4 hours. Standard lab cultures take longer and may miss some germs. The goal is to see if this faster method gives a more complete picture of the infection, which could help doctors choose the right antibiotics sooner. The trial will compare results from the new device with traditional culture methods using bone samples from 43 patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MinION nanopore sequencing device
What this could lead to
If successful, this could lead to faster, more accurate diagnosis of foot infections in people with diabetes, helping doctors choose the right antibiotics sooner.
What could go wrong
This is a small, early-stage study (43 participants) comparing a new method to standard culture. The tool may not be widely available or practical in all clinics, and results need confirmation in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetes Complications diabetes mellitus Diabetic Foot diabetic neuropathy Infections osteomyelitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Nîmes University Hospital

    RECRUITING

    Nîmes, Gard, 30029, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.